Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 38 citing articles:

Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy
Xiaogang Zheng, Xiaodong Jin, Fei Ye, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 48
Flavonoid 4,4′-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECH
Changmei Yang, Tianxiang Wang, Yujiao Zhao, et al.
Free Radical Biology and Medicine (2022) Vol. 188, pp. 14-23
Open Access | Times Cited: 49
CHAC1 as a Novel Contributor of Ferroptosis in Retinal Pigment Epithelial Cells with Oxidative Damage
Ye Liu, Di Wu, Qiuli Fu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1582-1582
Open Access | Times Cited: 40
Cancer associated fibroblast secreted miR-432-5p targets CHAC1 to inhibit ferroptosis and promote acquired chemoresistance in prostate cancer
Jun Zhao, Jijie Shen, Liang Mao, et al.
Oncogene (2024) Vol. 43, Iss. 27, pp. 2104-2114
Open Access | Times Cited: 15
Molecular mechanisms of ferroptosis and its role in prostate cancer therapy
Shaokun Wang, Wei Wei, Ning Ma, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 176, pp. 103732-103732
Open Access | Times Cited: 30
Glutathione‑degrading enzymes in the complex landscape of tumors (Review)
Tianyi Zhang, Chongjie Yao, Xu Zhou, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 1
Open Access | Times Cited: 7
Ferroptosis and ferroptosis-inducing nanomedicine as a promising weapon in combination therapy of prostate cancer
Mengjun Huang, Qiliang Teng, Fei Cao, et al.
Biomaterials Science (2024) Vol. 12, Iss. 7, pp. 1617-1629
Closed Access | Times Cited: 6
Roles of ferroptosis in urologic malignancies
Shankun Zhao, Peng Li, Weizhou Wu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 37
CHAC1 promotes cell ferroptosis and enhances radiation sensitivity in thyroid carcinoma
Xinlin Yang, Miao Zhang, Wei Xia, et al.
Neoplasma (2024) Vol. 70, Iss. 06, pp. 777-786
Open Access | Times Cited: 5
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 615-637
Closed Access | Times Cited: 5
CHAC1: a master regulator of oxidative stress and ferroptosis in human diseases and cancers
Jiasen Sun, Hui Ren, Jiawen Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
The role of ferroptosis in prostate cancer: a novel therapeutic strategy
Yue Wang, Yifan Ma, Kui Jiang
Prostate Cancer and Prostatic Diseases (2022) Vol. 26, Iss. 1, pp. 25-29
Open Access | Times Cited: 19
ChaC1 upregulation reflects poor prognosis in a variety of cancers: analysis of the major missense SNPs of ChaC1 as an aid to refining prognosis
Devraj Parande, Shradha Suyal, Anand Bachhawat
Gene (2024) Vol. 913, pp. 148386-148386
Closed Access | Times Cited: 4
The critical role of endoplasmic reticulum stress and the stimulator of interferon genes (STING) pathway in kidney fibrosis.
Magaiver Andrade-Silva, Poonam Dhillon, Andrea Sánchez‐Navarro, et al.
Kidney International (2024)
Closed Access | Times Cited: 4
Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
Thomas E. Hickey, Uma Mudunuri, Heidi Hempel, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
The PERK-eIF2α-ATF4 Axis Is Involved in Mediating ER-Stress-Induced Ferroptosis via DDIT4-mTORC1 Inhibition and Acetaminophen-Induced Hepatotoxicity
Thu-Hang Thi Nghiem, Kim Anh Nguyen, Fedho Kusuma, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 307-307
Open Access
Unravelling the antitumor mechanism of Ocoxin through cancer cell genomics
Iera Hernandez-Unzueta, Uxue Telleria-Gonzalez, Ana M. Aransay, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Self‐Assembled Acid‐Responsive Nanosystem for Synergistic Anti‐Angiogenic/Photothermal/Ferroptosis Therapy against Esophageal Cancer
Xiaokun Li, Jiamei Li, Siqin He, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 6
Closed Access | Times Cited: 10
Exploring a ferroptosis and oxidative stress-based prognostic model for clear cell renal cell carcinoma
Dongxu Lin, Bintao Hu, Shiqing Zhu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Ferroptosis landscape in prostate cancer from molecular and metabolic perspective
Jiaming Liang, Yihao Liao, Pu Wang, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 9
MIA3 promotes the degradation of GSH (glutathione) by binding to CHAC1, thereby promoting the progression of hepatocellular carcinoma
Zhou Wanbiao, Jing Man, Shi Zuo, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 10, pp. 2769-2784
Open Access | Times Cited: 7
CHAC1 blockade suppresses progression of lung adenocarcinoma by interfering with glucose metabolism via hijacking PKM2 nuclear translocation
Junfan Pan, Sixuan Wu, Qihong Pan, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 10
Open Access | Times Cited: 2
Culture of Cancer Cells at Physiological Oxygen Levels Affects Gene Expression in a Cell-Type Specific Manner
Ricardo Alva, Fereshteh Moradi, Ping Liang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1684-1684
Open Access | Times Cited: 10
Gene Expression Profiling Elucidates Cellular Responses to NCX4040 in Human Ovarian Tumor Cells: Implications in the Mechanisms of Action of NCX4040
Birandra K. Sinha, Erik J. Tokar, Jianying Li, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 285-285
Open Access | Times Cited: 10
Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models
Lijuan Bai, Xin Li, Yang Yang, et al.
Translational Oncology (2023) Vol. 34, pp. 101707-101707
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top